Navigation Links
Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
Date:11/10/2008

ose used for medical purposes. It also manufactures and supplies glucose and cornstarch products to the food, beverage and industrial production industries in China. For more information about Shengtai Pharmaceutical, Inc., please visit http://www.shengtaipharmaceutical.com .

Safe Harbor Statement

Certain statements in this press release and oral statements made by the Company constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, without limitation, statements regarding our ability to prepare the Company for growth, the Company's planned capacity expansion in 2008 and predictions and guidance relating to the Company's future financial performance. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs, but they involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand especially in the pharmaceutical industry, pricing and demand trends for the Company's products, changes to government regulations, risk associated with operation of the Company's new facilities, risk associated with large-scale implementation of the Company's business plan, the ability to attract new customers, ability to increase its product's applications, cost of raw materials, downturns in the Chinese economy, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. Investors are urged to consider these factors carefully in evaluating the forward-looki
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
2. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
3. Shengtai Pharmaceutical, Inc. Appoints New CFO
4. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
5. Potentia Pharmaceuticals Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
6. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
7. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
8. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
9. Critical Pharmaceuticals Raise GBP650K
10. WellSpring Pharmaceutical Corp. Announces Hire of Wayne Miller as Vice President, Sales & Marketing, Consumer Brands
11. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...HANGHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma an...evolution. The companies are facing significant,p...eting R&D costs, calls for,lower prices and a ...er with,the financial crisis have made the work of...utical companies are being forced to globalize the...
(Date:11/9/2009)... Four of the top 10 pharmaceutical g...ubmissions to Health Canada. Datafarm’s anno...th Canadian DIA Annual Meeting where Health Canada...nies may submit Hybrid eCTD regulatory submissions...o prior permission request. , ...
(Date:11/8/2009)...6, 2009 As global temperatures and energy costs c...be key to a sustainable future. An attractive re...ies published online in Genome Research ( www.ge...ructures of bioethanol-producing microorganisms, u...eveloping new technologies needed to implement pro...
(Date:11/6/2009)...TO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosy... has re-filed the Form 52-109F1 Certification of A...ve Officer and James Long, the Chief Financial Off...12, 2009 in connection with the annual audited fin... 2008. ,, The Company initially filed the annua...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2
...w Generation,Biofuels Holdings, Inc. (Nasdaq: NGB...hat David Gillespie, President & CEO, is scheduled...Investment Conference on Monday,November 10th, at ...able,for one-on-one meetings during the day. The c...l in New York City. The presentation will be webca...
...oGenomics, Inc.,(OTC Bulletin Board: NGNM) announc...er, Bob Gasparini, will present at the Rodman & Re... from November 10-12, 2008 at,the New York Palace ...se,over 350 small and microcap public life science...r executives of attending companies will make,pres...
...orporation (Nasdaq:,DNDN) today reported results f...or the third quarter of 2008 was $26,000 compared ...07. Revenue for the nine months ended,September 30...ne months,ended September 30, 2007., Dendreon,s t...008 were,$17.3 million compared to $19.8 million i...
Other Biology Technology:New Generation Biofuels CEO to Present at the Rodman & Renshaw Annual Global Investment Conference 2NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10 2Dendreon Reports Third Quarter 2008 Financial Results 2Dendreon Reports Third Quarter 2008 Financial Results 3Dendreon Reports Third Quarter 2008 Financial Results 4Dendreon Reports Third Quarter 2008 Financial Results 5
(Date:11/9/2009)...HILADELPHIA Scientists and industry leaders from ... 2009, for the AACR-NCI-EORTC Molecular Targets an...ich will feature groundbreaking information on imp...er is a complex disease and to treat it effectivel...that takes place at the molecular level," said Lew...
(Date:11/8/2009)... HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTEL... LIVES , An Indiana University study involving ...he adults increased their personal health knowledg... , Adults with ID, an internationally accepted ...rates of obesity, physical inactivity and preventa...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, M...LEID) will be installing its locker system and pat...ACS) at the U.S. Department of Health and Human Se...in Bethesda, MD. The locker system will support t...or protecting our nation,s medical research agency...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Bio enabled surface mediated approach produces nanoparticle composites 13633 1Bio enabled surface mediated approach produces nanoparticle composites 13633 2Bio enabled surface mediated approach produces nanoparticle composites 13633 3Living longer and happier 54930 1Living longer and happier 54930 2Kaiser Workers Launch Statewide Pickets 54929 1
... Depression, anxiety disorders such as panic diso...and drug dependence, dementia and Parkinsons disea...ain. The size, the burden and cost of brain disord...erestimated, as Prof. Dr. Hans Ulrich Wittchen ,em...0th ECNP Congress for ,Neuropsychopharmacology in ...
... Even early in adulthood, aging begins to slow th... altogether, suggests a Princeton University study...roscientists has found that soon after marmoset mo...l cells form in the hippocampus region of the anim...associated with both learning and memory. While ot...
... PHILADELPHIA, PA, October 15, 2007- Clinical dat...rican College of Gastroenterology (ACG) show that ...lectomy surgeries for patients with moderately to ...g to a primary analysis of long-term extension dat...s (ACT trials), there is a 41 percent reduction in...
Other Biology News:Mental disorders are disorders of the brain 2Mental disorders are disorders of the brain 3Brain cell growth diminishes long before old age strikes, animal study shows 2Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 2Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 3Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 4Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 5Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 6
Agilent ChemStation Base Software from Agilent Technologies
Mouse Anti-HLA, Class II Antigen-DR+DP Monoclonal Antibody, Unconjugated, Clone 236-14240 from Meridian Life Science, Inc.
...lly clear polystyrene with frosted labeling surfac...s for cell counting. 100% integrity tested. Linkag...d to easily match Cornings product number. If show...d Sigma-Aldrich number (C0177) or contact customer...
Rabbit Anti-iNOS / NOS Type II Polyclonal Antibody, Unconjugated from BD Biosciences Pharmingen
Biology Products: